Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]        
Revenues $ 16,742,000 $ 14,457,000 $ 49,697,000 $ 47,447,000
Cost of sales 11,455,000 10,432,000 33,729,000 33,806,000
Gross profit 5,287,000 4,025,000 15,968,000 13,641,000
Operating expenses:        
Selling and administrative 5,717,000 5,311,000 16,817,000 14,629,000
Research and development 1,147,000 1,286,000 3,419,000 3,816,000
Total operating expenses 6,864,000 6,597,000 20,236,000 18,445,000
Operating loss (1,577,000) (2,572,000) (4,268,000) (4,804,000)
Interest income (expense), net (362,000) (433,000) (1,227,000) (1,285,000)
Net loss $ (1,939,000) $ (3,005,000) $ (5,495,000) $ (6,089,000)
Net loss per share - basic $ (0.12) $ (0.18) $ (0.33) $ (0.37)
Net loss per share - diluted $ (0.12) $ (0.18) $ (0.33) $ (0.37)
Weighted average number of common shares outstanding - basic 16,684,320 16,538,998 16,683,074 16,510,046
Weighted average number of common shares outstanding - diluted 16,684,320 16,538,998 16,683,074 16,510,046